| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PATH.1931 |
| P698 | PubMed publication ID | 16450335 |
| P2093 | author name string | D Liu | |
| C Huang | |||
| T Nakashima | |||
| M Ueno | |||
| N Nakashima | |||
| S Sumitomo | |||
| D Masuya | |||
| H Yokomise | |||
| P2860 | cites work | Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death | Q24312211 |
| P433 | issue | 5 | |
| P921 | main subject | carcinogenesis | Q1637543 |
| P304 | page(s) | 724-732 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | The HAUSP gene plays an important role in non-small cell lung carcinogenesis through p53-dependent pathways | |
| P478 | volume | 208 |
| Q36289021 | A herpesvirus ubiquitin-specific protease is critical for efficient T cell lymphoma formation. |
| Q39991228 | A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model |
| Q53538898 | Active-site directed probes to report enzymatic action in the ubiquitin proteasome system. |
| Q38326071 | Deubiquitinases and the new therapeutic opportunities offered to cancer |
| Q21284381 | Deubiquitylating enzymes and disease |
| Q48265884 | Deubiquitylating enzymes and drug discovery: emerging opportunities. |
| Q59357734 | Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases |
| Q37674364 | Emerging roles of deubiquitinases in cancer-associated pathways |
| Q57082634 | Emerging roles of proteases in tumour suppression |
| Q36858443 | Expression of HAUSP in gliomas correlates with disease progression and survival of patients |
| Q35828658 | FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC. |
| Q40155261 | Hyperubiquitylation of wild-type p53 contributes to cytoplasmic sequestration in neuroblastoma |
| Q28075457 | Modulation of the p53/MDM2 interplay by HAUSP inhibitors |
| Q92529034 | Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease |
| Q26770579 | Regulation of Mutant p53 Protein Expression |
| Q28303730 | Stressing the role of FoxO proteins in lifespan and disease |
| Q38847962 | Structural Characterization of Interaction between Human Ubiquitin-specific Protease 7 and Immediate-Early Protein ICP0 of Herpes Simplex Virus-1. |
| Q92002855 | Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet? |
| Q36065142 | The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin. |
| Q37381637 | The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis. |
| Q28253741 | The emerging roles of forkhead box (Fox) proteins in cancer |
| Q55361439 | USP49 participates in the DNA damage response by forming a positive feedback loop with p53. |
| Q98771728 | USP7 Is a Master Regulator of Genome Stability |
| Q63246433 | USP7 Regulates Cytokinesis through FBXO38 and KIF20B |
| Q35221054 | USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma |
| Q89737230 | USP7 stabilizes EZH2 and enhances cancer malignant progression |
| Q64079043 | USP7: Novel Drug Target in Cancer Therapy |
| Q36601000 | Ubiquitin and ubiquitin-like proteins in cancer pathogenesis |
| Q37409763 | Ubiquitin at the crossroad of cell death and survival |
| Q34503492 | Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets |
| Q37820063 | Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets |
| Q38698832 | Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis |
| Q37991651 | Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer |
| Q38021448 | Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications |
| Q61124626 | Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie |
| Q34300569 | p53 post-translational modification: deregulated in tumorigenesis |
Search more.